Clinical Research Directory
Browse clinical research sites, groups, and studies.
AIMS Cancer Outcomes Study
Sponsor: Advanced Integrative Medical Science Institute
Summary
The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.
Official title: Advanced Integrative Oncology Treatment for Adult and Pediatric Patients With Cancer: A Prospective Outcomes Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2020-05-18
Completion Date
2030-12-31
Last Updated
2023-02-01
Healthy Volunteers
No
Locations (1)
AIMS Institute
Seattle, Washington, United States